TAKEDA PHARMACEUTIC-SP ADR (TAK) Stock Income Statement
USA - NYSE:TAK - US8740602052 - ADR
14.29 USD
+0.05 (+0.35%)
14.29 USD
0 (0%)
| TTM (2025-9-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.42T | 4.58T | 4.26T | 4.03T | 3.57T | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | -211.00M | -215.00M | -130.00M | -21.00M | -107.00M | |||
| Cost Of Goods | 1.56T | 1.58T | 1.43T | 1.24T | 1.11T | |||
| Gross Profit | 2.85T | 3.00T | 2.84T | 2.78T | 2.46T | |||
| Operating Expenses | 2.48T | 2.46T | 2.41T | 2.23T | 1.92T | |||
| Research and Development | 691.57B | 730.23B | 729.92B | 633.33B | 526.09B | |||
| Selling, General, and Administrative Expenses | 1.08T | 1.10T | 1.05T | 997.31B | 886.36B | |||
| Operating Income | 373.58B | 537.03B | 430.79B | 550.89B | 545.49B | |||
| Interest Income/Expense | -147.66B | -181.97B | -196.48B | -158.20B | -142.63B | |||
| Other Income/Expense | null | 0 | 1.00M | null | 1.00M | |||
| Non Recurring Items | -128.01B | -179.97B | -181.51B | -17.60B | -100.29B | |||
| Income Before Taxes | 97.91B | 175.08B | 52.79B | 375.09B | 302.57B | |||
| Income Tax | 64.63B | 66.94B | -91.41B | 58.05B | 72.41B | |||
| Net Income | 33.08B | 107.93B | 144.07B | 317.02B | 230.06B | |||
| EBITDA | 1.12T | 1.30T | 1.16T | 1.22T | 1.13T | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 10.798932596171452 | 34.132756038102826 | 45.981921904239016 | 100.83302956947013 | 72.83589677801436 | |||
| Non GAAP EPS | 10.699756381613192 | 34.13395442152312 | 45.9830803415453 | 102.07310175300302 | 73.53425970945798 | |||
| Statistics | ||||||||
| Gross Profit Margin | 64.60% | 65.51% | 66.54% | 69.11% | 68.99% | |||
| Profit Margin | 0.75% | 2.36% | 3.38% | 7.87% | 6.45% | |||
| Operating Profit Margin | 8.46% | 11.72% | 10.10% | 13.68% | 15.28% | |||
All data in JPY